Publication and non-publication of clinical trials in PTSD: an overview

被引:4
|
作者
Suliman, Sharain [1 ]
van den Heuvel, Leigh [1 ]
Suryapranata, Alexandra [1 ]
Bisson, Jonathan, I [2 ]
Seedat, Soraya [1 ]
机构
[1] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Psychiat, POB 19063, ZA-7505 Tygerberg, South Africa
[2] Cardiff Univ, Div Psychol Med & Clin Neurosci, Sch Med, Cardiff, Wales
基金
英国医学研究理事会;
关键词
Trial registry; Posttraumatic stress disorder; Publication; REDUCING WASTE; REGISTRATION; PSYCHOLOGY; TIME;
D O I
10.1186/s41073-019-0074-6
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
BackgroundAlthough a large number of clinical trials on interventions demonstrating efficacy (or lack thereof) are conducted annually, much of this evidence is not accessible to scientists and clinicians.ObjectivesWe aimed to determine the publication rate of posttraumatic stress disorder (PTSD) trials that have been registered in clinical trial registries, and the factors associated with publication.MethodsTrials, completed on January 15, 2015, were identified via the US National Institutes of Health clinical trials registry, the European Union Clinical Trials Register and the WHO International Clinical Trials Registry Platform. A systematic search for publications (published by the end of March 2018) related to each of the registered trials were then performed.ResultsFour hundred and thirty-eight of 1982 potentially eligible trials were included. Only 34% of interventional trials were registered prior to initiation, 9% were registered within 2 months of starting and 20% after trial completion. Of the 438 included trials, 72% had generated peer-reviewed publications, while an additional 7% had disseminated results in some other form (such as on the trial database), 26 months after trial completion. Randomisation of a trial was the only factor individually associated with publication, in logistic regression analysis (p<0.001). Intervention type, university as sponsor and study registration prior to completion were factors that influenced the time to publication, using Cox regression (p<0.001).ConclusionsThis study underscores the importance of timely and accurate publication and dissemination of trial results, in order to avoid the potential waste of resources and to ensure research integrity and patient safety. We suggest that authors and journal editors adhere to conditions set out by the International Committee of Medical Journal Editors and that more diligent data sharing is encouraged through prospective trial registration and trial reporting websites.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Discontinuation and Non-Publication of Stroke Clinical Studies: A Cross-Sectional Analysis
    Aljabali, Ahmed
    Alkhawaldeh, Ibraheem M.
    Abdelhady, Mariam
    Goudy, Yomna
    Allam, Ahmed
    Temraz, Heba
    Hamad, Abdullah
    Reda, Eman
    Arar, Amina
    Hefnawy, Mahmoud
    Diab, Rehab
    Elbaz, Zainab
    Abdelazim, Marwa
    Nabil, Amir
    Abdalla, Yomna
    Ghaith, Hazem
    Negida, Ahmed
    [J]. ANNALS OF NEUROLOGY, 2023, 94 : S104 - S104
  • [32] Discontinuation and non-publication of randomised clinical trials supported by the main public funding body in Switzerland: a retrospective cohort study
    Amstutz, Alain
    Schandelmaier, Stefan
    Frei, Roy
    Surina, Jakub
    Agarwal, Arnav
    Olu, Kelechi Kalu
    Alturki, Reem
    Von Niederhausern, Belinda
    Von Elm, Erik
    Briel, Matthias
    [J]. BMJ OPEN, 2017, 7 (07):
  • [33] Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug Trials
    van den Bogert, Cornelis A.
    Souverein, Patrick C.
    Brekelmans, Cecile T. M.
    Janssen, Susan W. J.
    Koeter, Gerard H.
    Leufkens, Hubert G. M.
    Bouter, Lex M.
    [J]. PLOS ONE, 2016, 11 (12):
  • [35] Registration of clinical trials for publication
    Cook, Chad
    Jull, Gwendolen
    Moore, Ann
    [J]. MANUAL THERAPY, 2014, 19 (04) : 279 - 280
  • [36] Publication of clinical drug trials
    Nahata, MC
    [J]. ANNALS OF PHARMACOTHERAPY, 2001, 35 (06) : 780 - 781
  • [37] Non-publication and negative studies: their significance to opinion forming and research
    Menger, MD
    Vollmar, B
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 125 (38) : 1129 - 1130
  • [38] Making Austen mad:: Benjamin!Crosby and the non-publication of 'Susan'
    Mandal, A. A.
    [J]. REVIEW OF ENGLISH STUDIES, 2006, 57 (231): : 507 - 525
  • [39] Discontinuation and non-publication of heart failure randomized controlled trials: a call to publish all trial results
    Khan, Muhammad Shahzeb
    Shahid, Izza
    Asad, Nava
    Greene, Stephen J.
    Khan, Safi U.
    Doukky, Rami
    Metra, Marco
    Anker, Stefan D.
    Filippatos, Gerasimos S.
    Fonarow, Gregg C.
    Butler, Javed
    [J]. ESC HEART FAILURE, 2021, 8 (01): : 16 - 25
  • [40] Is there resource wastage in the research for spinal diseases? An observational analysis of discontinuation and non-publication in randomised controlled trials
    Demetriades, Andreas K.
    Park, Jay J.
    Tiefenbach, Jakov
    [J]. BRAIN AND SPINE, 2022, 2